430 related articles for article (PubMed ID: 9131203)
21. [Clinical evaluation of amiodarone hydrochloride as an anti-arrhythmia agent].
Malpartida F; Triola M; Huguet R; Sala J; Noguera J; Cordeiro B
Rev Med Univ Navarra; 1975; 19(1):143-9. PubMed ID: 1234780
[TBL] [Abstract][Full Text] [Related]
22. What have clinical trials taught us about proarrhythmia?
Skanes AC; Green MS
Can J Cardiol; 1996 Apr; 12 Suppl B():20B-26B. PubMed ID: 8616725
[TBL] [Abstract][Full Text] [Related]
23. Amiodarone in the prevention and treatment of arrhythmia.
Auer J; Berent R; Eber B
Curr Opin Investig Drugs; 2002 Jul; 3(7):1037-44. PubMed ID: 12186264
[TBL] [Abstract][Full Text] [Related]
24. Antiarrhythmic therapy in heart failure.
Eckardt L; Haverkamp W; Breithardt G
Heart Fail Monit; 2002; 2(4):110-9. PubMed ID: 12634885
[TBL] [Abstract][Full Text] [Related]
25. [Arrhythmia risk stratification in patients with heart failure according to drug treatment and its effects].
Gronda E; Mangiavacchi M; Andreuzzi B; Municinò A
Ital Heart J Suppl; 2001 Dec; 2(12):1278-83. PubMed ID: 11838348
[TBL] [Abstract][Full Text] [Related]
26. Randomised trial of effect of amiodarone on mortality in patients with left-ventricular dysfunction after recent myocardial infarction: EMIAT. European Myocardial Infarct Amiodarone Trial Investigators.
Julian DG; Camm AJ; Frangin G; Janse MJ; Munoz A; Schwartz PJ; Simon P
Lancet; 1997 Mar; 349(9053):667-74. PubMed ID: 9078197
[TBL] [Abstract][Full Text] [Related]
27. [Clinical study on the ventricular antiarrhythmic effects of amiodarone (oral and injectable)].
Fauchier JP; Brochier M; Raynaud R
Ann Cardiol Angeiol (Paris); 1973 Oct; 22(5):427-35. PubMed ID: 4770689
[No Abstract] [Full Text] [Related]
28. Amiodarone in congestive heart failure.
Singh S
Int J Clin Pract; 1998 Sep; 52(6):432-5. PubMed ID: 9894384
[TBL] [Abstract][Full Text] [Related]
29. Should post-infarction asymptomatic ventricular arrhythmias be treated? The need for caution.
Sleight P
Eur Heart J; 1995 Jul; 16 Suppl E():49. PubMed ID: 8542884
[No Abstract] [Full Text] [Related]
30. Implantable defibrillators and/or amiodarone: alternatives or complementary therapies.
Dorian P; Newman D; Greene M
Int J Clin Pract; 1998 Sep; 52(6):425-8. PubMed ID: 9894382
[TBL] [Abstract][Full Text] [Related]
31. Antiarrhythmic trials: a decade of growth.
Kanjwal MY
Indian Heart J; 1998; 50(3):277-84. PubMed ID: 9753848
[No Abstract] [Full Text] [Related]
32. [Importance of programmed ventricular stimulation in the evaluation of proarrhythmic effects of orally administered anti-arrhythmia agents].
Pleskot M; Pidrman V; Tilser P; Parízek P
Vnitr Lek; 1995 Sep; 41(9):581-5. PubMed ID: 7483346
[TBL] [Abstract][Full Text] [Related]
33. Amiodarone and mortality among elderly patients with acute myocardial infarction with atrial fibrillation.
Kilborn MJ; Rathore SS; Gersh BJ; Oetgen WJ; Solomon AJ
Am Heart J; 2002 Dec; 144(6):1095-101. PubMed ID: 12486436
[TBL] [Abstract][Full Text] [Related]
34. Effect of antiarrhythmic therapy on mortality in survivors of myocardial infarction with asymptomatic complex ventricular arrhythmias: Basel Antiarrhythmic Study of Infarct Survival (BASIS).
Burkart F; Pfisterer M; Kiowski W; Follath F; Burckhardt D
J Am Coll Cardiol; 1990 Dec; 16(7):1711-8. PubMed ID: 2254558
[TBL] [Abstract][Full Text] [Related]
35. Catheter ablation and antiarrhythmic drugs for haemodynamically tolerated post-infarction ventricular tachycardia; long-term outcome in relation to acute electrophysiological findings.
Della Bella P; De Ponti R; Uriarte JA; Tondo C; Klersy C; Carbucicchio C; Storti C; Riva S; Longobardi M
Eur Heart J; 2002 Mar; 23(5):414-24. PubMed ID: 11846499
[TBL] [Abstract][Full Text] [Related]
36. [Anti-arrhythmic effects of injectable amiodarone. Apropos of 100 cases].
Benaim R; Denizeau JP; Melon J; Domengie B; Kolsky H; Chapelle M; Chiche P
Arch Mal Coeur Vaiss; 1976 May; 69(5):513-22. PubMed ID: 821421
[TBL] [Abstract][Full Text] [Related]
37. Amiodarone use after acute myocardial infarction complicated by heart failure and/or left ventricular dysfunction may be associated with excess mortality.
Thomas KL; Al-Khatib SM; Lokhnygina Y; Solomon SD; Kober L; McMurray JJ; Califf RM; Velazquez EJ
Am Heart J; 2008 Jan; 155(1):87-93. PubMed ID: 18082495
[TBL] [Abstract][Full Text] [Related]
38. [Ventricular arrhythmias: diagnosis and drug therapy].
Schüpfer C; Gertsch M
Praxis (Bern 1994); 1996 May; 85(20):647-54. PubMed ID: 8685556
[TBL] [Abstract][Full Text] [Related]
39. Potential impact of antiarrhythmic drugs versus implantable defibrillators on the management of ventricular arrhythmias: the Midlands trial of empirical amiodarone versus electrophysiologically guided intervention and cardioverter implant registry data.
Pathmanathan RK; Lau EW; Cooper J; Newton L; Skehan JD; Garratt CJ; Griffith MJ
Heart; 1998 Jul; 80(1):68-70. PubMed ID: 9764063
[TBL] [Abstract][Full Text] [Related]
40. Secondary prevention after myocardial infarction with class III antiarrhythmic drugs.
Ceremuzyński L
Am J Cardiol; 1993 Nov; 72(16):82F-86F. PubMed ID: 8237835
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
